Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue SarcomaMrinal M. Gounder, Albiruni Ryan Abdul Razak, Mary Louise Keohan et al.|Journal of Clinical Oncology|2016Cited by 165
Immunoprofiling in alveolar soft part sarcoma.Samer Salah, Albiruni Ryan Abdul Razak, Jeremy Lewin et al.|Journal of Clinical Oncology|2017Cited by 6
Immune signature and molecular profiling of radiation-induced sarcoma (RIS).Eoghan Ruadh Malone, Albiruni Ryan Abdul Razak, Jeremy Lewin et al.|Journal of Clinical Oncology|2019Cited by 3